Shortly after a positive data drop for Eli Lilly’s efsitora a | Lilly revealed that its weekly insulin candidate efsitora ...

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...

The use of GLP-1R agonists could be a great opportunity for patients whose diabetes is not completely under control with ...

Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Introduction ADVERTISEMENT Peptides have become a focal point in research due to their intricate interactions with metabolic ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

Explore insights from the SURPASS-4 trial, highlighting key predictors for long-term success in managing Type 2 diabetes with tirzepatide, presented at the EASD Annual Meeting.

Sugar addiction is very different from drug addiction; however, there are some similarities. Learn about ways to help detox ...

When hormones like insulin and glucagon are released in the body, it reduces hunger, decreases appetite and food intake, and makes you feel fuller for longer, all resulting in weight loss.